Abstract
An abnormal substance in the plasma of certain diabetic patients enhances platelet aggregation. There is a correlation between the severity of diabetic retinopathy and the degree of platelet-aggregationenhancing activity in the plasma of adult diabetics. We postulate that increased platelet aggregation leads to the development of ischemic retinal lesions and thereby plays a significant role in the genesis of diabetic retinopathy. Aspirin blocks the action of the aggregation-enhancing activity of diabetic plasma nonspecifically, although it has no effect on the plasma level of the factor. Therefore, therapy with aspirin may be of value in the prevention of diabetic retinopathy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
